Cancer Clinical Trial
— SAVE-ONCOOfficial title:
A Multinational, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AVE5026 in the Prevention of Venous Thromboembolism (VTE) in Cancer Patients at High Risk for VTE and Who Are Undergoing Chemotherapy
| Verified date | January 2013 |
| Source | Sanofi |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Food and Drug Administration |
| Study type | Interventional |
The primary objective was to compare the efficacy of once daily subcutaneous injections of
Semuloparin sodium (AVE5026) with placebo in the prevention of venous thromboembolism [VTE]
in cancer patients at high risk for VTE and who were undergoing chemotherapy.
The secondary objectives were to evaluate the safety of Semuloparin sodium (AVE5026), to
document Semuloparin sodium (AVE5026) exposures, to try identifying a metagene predictor of
VTE and to assess the survival status at one year in this population.
| Status | Completed |
| Enrollment | 3212 |
| Est. completion date | November 2010 |
| Est. primary completion date | November 2010 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: Cancer patient with metastatic or locally advanced solid tumor of lung, pancreas, stomach, colon/rectum, bladder or ovary initiating a (new) course of chemotherapy with a minimum intent of 3 months therapy Exclusion Criteria: - Required systematic venous thromboprophylaxis or curative treatment with anti-coagulant or thrombolytic; - High risk of bleeding; - Severe renal impairment (estimated creatinine clearance <30 mL/min); - ECOG (Eastern Cooperative Oncology Group) performance status 3 & 4; - Major surgery within 4 weeks before randomization; - Known hypersensitivity to unfractionated heparin [UFH] or low molecular weight heparin [LMWH]. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
| Country | Name | City | State |
|---|---|---|---|
| Argentina | Investigational Site Number 032006 | Buenos Aires | |
| Argentina | Investigational Site Number 032003 | Capital Federal | |
| Argentina | Investigational Site Number 032004 | Rosario | |
| Argentina | Investigational Site Number 032005 | San Miguel De Tucuman | |
| Argentina | Investigational Site Number 032007 | Tucuman | |
| Australia | Investigational Site Number 036004 | Adelaide | |
| Australia | Investigational Site Number 036002 | Bedford Park | |
| Australia | Investigational Site Number 036001 | Box Hill | |
| Australia | Investigational Site Number 036009 | Lismore | |
| Australia | Investigational Site Number 036007 | Perth | |
| Australia | Investigational Site Number 036006 | Ringwood East | |
| Australia | Investigational Site Number 036008 | Westmead | |
| Australia | Investigational Site Number 036003 | Woodville | |
| Australia | Investigational Site Number 036005 | Woolloongabba | |
| Austria | Investigational Site Number 040002 | Graz | |
| Austria | Investigational Site Number 040003 | Wien | |
| Austria | Investigational Site Number 040004 | Wien | |
| Belarus | Investigational Site Number 112002 | Gomel | |
| Belarus | Investigational Site Number 112001 | Minsk | |
| Belarus | Investigational Site Number 112003 | Minsk | |
| Belarus | Investigational Site Number 112004 | Vitebsk | |
| Belgium | Investigational Site Number 056008 | Bonheiden | |
| Belgium | Investigational Site Number 056011 | Brussels | |
| Belgium | Investigational Site Number 056005 | Gent | |
| Belgium | Investigational Site Number 056010 | Haine-Saint-Paul | |
| Belgium | Investigational Site Number 056006 | Kortrijk | |
| Belgium | Investigational Site Number 056009 | Liège | |
| Belgium | Investigational Site Number 056004 | Merksem | |
| Belgium | Investigational Site Number 056003 | Oostende | |
| Belgium | Investigational Site Number 056012 | Ottignies | |
| Belgium | Investigational Site Number 056002 | Sint Niklaas | |
| Brazil | Investigational Site Number 076002 | Belo Horizonte | |
| Brazil | Investigational Site Number 076015 | Curitiba | |
| Brazil | Investigational Site Number 076022 | Curitiba | |
| Brazil | Investigational Site Number 076012 | Florianopolis | |
| Brazil | Investigational Site Number 076001 | Fortaleza | |
| Brazil | Investigational Site Number 076007 | Goiania | |
| Brazil | Investigational Site Number 076009 | Goiania | |
| Brazil | Investigational Site Number 076016 | Goiania | |
| Brazil | Investigational Site Number 076024 | Ijui | |
| Brazil | Investigational Site Number 076003 | Joinville | |
| Brazil | Investigational Site Number 076010 | Londrina | |
| Brazil | Investigational Site Number 076026 | Passo Fundo | |
| Brazil | Investigational Site Number 076027 | Passo Fundo | |
| Brazil | Investigational Site Number 076020 | Porto Alegre | |
| Brazil | Investigational Site Number 076023 | Porto Alegre | |
| Brazil | Investigational Site Number 076014 | Salvador | |
| Brazil | Investigational Site Number 076018 | Salvador | |
| Brazil | Investigational Site Number 076011 | Santo Andre | |
| Brazil | Investigational Site Number 076006 | Sao Jose Dos Campos | |
| Brazil | Investigational Site Number 076008 | Sao Paulo | |
| Brazil | Investigational Site Number 076017 | Sao Paulo | |
| Brazil | Investigational Site Number 076004 | Taguatinga | |
| Bulgaria | Investigational Site Number 100001 | Rousse | |
| Bulgaria | Investigational Site Number 100003 | Varna | |
| Canada | Investigational Site Number 124008 | Greenfield Park | |
| Canada | Investigational Site Number 124007 | Kelowna | |
| Canada | Investigational Site Number 124010 | Moncton | |
| Canada | Investigational Site Number 124003 | Montreal | |
| Canada | Investigational Site Number 124002 | Ottawa | |
| Canada | Investigational Site Number 124009 | Owen Sound | |
| Canada | Investigational Site Number 124006 | Rimouski | |
| Canada | Investigational Site Number 124013 | Saint John | |
| Canada | Investigational Site Number 124001 | Sherbrooke | |
| Canada | Investigational Site Number 124012 | Victoria | |
| Canada | Investigational Site Number 124011 | Weston | |
| Chile | Investigational Site Number 152002 | Temuco | |
| China | Investigational Site Number 156008 | Beijing | |
| China | Investigational Site Number 156014 | Beijing | |
| China | Investigational Site Number 156022 | Beijing | |
| China | Investigational Site Number 156031 | Changchun | |
| China | Investigational Site Number 156021 | Chengdu | |
| China | Investigational Site Number 156019 | Chongqing | |
| China | Investigational Site Number 156003 | Dalian | |
| China | Investigational Site Number 156025 | Guangzhou | |
| China | Investigational Site Number 156026 | Hangzhou | |
| China | Investigational Site Number 156030 | Nanning | |
| China | Investigational Site Number 156029 | Qingdao | |
| China | Investigational Site Number 156011 | Shanghai | |
| China | Investigational Site Number 156020 | Shanghai | |
| China | Investigational Site Number 156024 | Shanghai | |
| China | Investigational Site Number 156028 | Shanghai | |
| China | Investigational Site Number 156013 | Shantou | |
| China | Investigational Site Number 156012 | Suzhou | |
| China | Investigational Site Number 156004 | Xi'An | |
| China | Investigational Site Number 156009 | Xi'An | |
| China | Investigational Site Number 156027 | Yinchuan | |
| Colombia | Investigational Site Number 170010 | Bogota | |
| Colombia | Investigational Site Number 170005 | Manizales | |
| Colombia | Investigational Site Number 170002 | Medellin | |
| Colombia | Investigational Site Number 170006 | Medellin | |
| Colombia | Investigational Site Number 170007 | Medellín | |
| Colombia | Investigational Site Number 170008 | Monteria | |
| Colombia | Investigational Site Number 170004 | Pereira | |
| Croatia | Investigational Site Number 191006 | Pula | |
| Croatia | Investigational Site Number 191005 | Rijeka | |
| Croatia | Investigational Site Number 191007 | Varazdin | |
| Croatia | Investigational Site Number 191003 | Zadar | |
| Croatia | Investigational Site Number 191001 | Zagreb | |
| Croatia | Investigational Site Number 191004 | Zagreb | |
| Croatia | Investigational Site Number 191008 | Zagreb | |
| Czech Republic | Investigational Site Number 203004 | Hradec Kralove | |
| Czech Republic | Investigational Site Number 203008 | Kolin | |
| Czech Republic | Investigational Site Number 203007 | Nova Ves Pod Plesi | |
| Czech Republic | Investigational Site Number 203003 | Praha 5 | |
| Denmark | Investigational Site Number 208001 | Herlev | |
| Estonia | Investigational Site Number 233001 | Tallinn | |
| Finland | Investigational Site Number 246001 | Turku | |
| France | Investigational Site Number 250002 | Antibes | |
| France | Investigational Site Number 250010 | Colmar | |
| France | Investigational Site Number 250020 | Gap | |
| France | Investigational Site Number 250005 | Lille Cedex | |
| France | Investigational Site Number 250012 | Lille Cedex | |
| France | Investigational Site Number 250025 | Lille Cedex | |
| France | Investigational Site Number 250003 | Lyon | |
| France | Investigational Site Number 250001 | Marseille | |
| France | Investigational Site Number 250024 | Montpellier Cedex | |
| France | Investigational Site Number 250006 | Paris Cedex 10 | |
| France | Investigational Site Number 250027 | Paris Cedex 10 | |
| France | Investigational Site Number 250004 | Paris Cedex 14 | |
| France | Investigational Site Number 250021 | Reims | |
| France | Investigational Site Number 250019 | Rouen | |
| France | Investigational Site Number 250017 | Saint Gregoire | |
| France | Investigational Site Number 250014 | Vandoeuvre Les Nancy | |
| Germany | Investigational Site Number 276012 | Augsburg | |
| Germany | Investigational Site Number 276002 | Berlin | |
| Germany | Investigational Site Number 276016 | Berlin | |
| Germany | Investigational Site Number 276025 | Berlin | |
| Germany | Investigational Site Number 276029 | Berlin | |
| Germany | Investigational Site Number 276004 | Bochum | |
| Germany | Investigational Site Number 276009 | Dresden | |
| Germany | Investigational Site Number 276014 | Dresden | |
| Germany | Investigational Site Number 276030 | Essen | |
| Germany | Investigational Site Number 276005 | Frankfurt Am Main | |
| Germany | Investigational Site Number 276032 | Gauting | |
| Germany | Investigational Site Number 276034 | Halle | |
| Germany | Investigational Site Number 276038 | Halle/Saale | |
| Germany | Investigational Site Number 276037 | Hamburg | |
| Germany | Investigational Site Number 276007 | Hannover | |
| Germany | Investigational Site Number 276006 | Köln | |
| Germany | Investigational Site Number 276020 | Leer | |
| Germany | Investigational Site Number 276010 | Leipzig | |
| Germany | Investigational Site Number 276017 | Magdeburg | |
| Germany | Investigational Site Number 276011 | Mannheim | |
| Germany | Investigational Site Number 276003 | Minden | |
| Germany | Investigational Site Number 276015 | München | |
| Germany | Investigational Site Number 276019 | München | |
| Germany | Investigational Site Number 276021 | München | |
| Germany | Investigational Site Number 276013 | Neumünster | |
| Germany | Investigational Site Number 276022 | Oldenburg | |
| Germany | Investigational Site Number 276035 | Paderborn | |
| Germany | Investigational Site Number 276031 | Passau | |
| Germany | Investigational Site Number 276023 | Rosenheim | |
| Germany | Investigational Site Number 276008 | Singen | |
| Germany | Investigational Site Number 276024 | Westerstede | |
| Greece | Investigational Site Number 300004 | Athens | |
| Greece | Investigational Site Number 300003 | Heraklion | |
| Greece | Investigational Site Number 300002 | Thessaloniki | |
| Hong Kong | Investigational Site Number 344001 | Hong Kong | |
| Hungary | Investigational Site Number 348004 | Budapest | |
| Hungary | Investigational Site Number 348005 | Budapest | |
| Hungary | Investigational Site Number 348006 | Budapest | |
| Hungary | Investigational Site Number 348009 | Budapest | |
| Hungary | Investigational Site Number 348010 | Farkasgyepu | |
| Hungary | Investigational Site Number 348001 | Gyula | |
| Hungary | Investigational Site Number 348012 | Mátraháza | |
| Hungary | Investigational Site Number 348003 | Sopron | |
| Hungary | Investigational Site Number 348008 | Szikszó | |
| Hungary | Investigational Site Number 348011 | Szolnok | |
| Hungary | Investigational Site Number 348007 | Zalaegerszeg | |
| India | Investigational Site Number 356006 | Bangalore | |
| India | Investigational Site Number 356008 | Bangalore | |
| India | Investigational Site Number 356009 | Bhopal | |
| India | Investigational Site Number 356018 | Chennai | |
| India | Investigational Site Number 356020 | Chennai | |
| India | Investigational Site Number 356019 | Coimbatore | |
| India | Investigational Site Number 356015 | Hyderabad | |
| India | Investigational Site Number 356025 | Hyderabad | |
| India | Investigational Site Number 356011 | Jaipur | |
| India | Investigational Site Number 356014 | Kochi | |
| India | Investigational Site Number 356003 | Kolkata | |
| India | Investigational Site Number 356013 | Kolkata | |
| India | Investigational Site Number 356017 | Kolkata | |
| India | Investigational Site Number 356005 | Madurai | |
| India | Investigational Site Number 356016 | Miraj | |
| India | Investigational Site Number 356001 | Mumbai | |
| India | Investigational Site Number 356023 | Nagpur | |
| India | Investigational Site Number 356002 | New Delhi | |
| India | Investigational Site Number 356004 | Pune | |
| India | Investigational Site Number 356024 | Pune | |
| India | Investigational Site Number 356012 | Vishakhapatnam | |
| Indonesia | Investigational Site Number 360002 | Bandung | |
| Indonesia | Investigational Site Number 360001 | Denpasar | |
| Indonesia | Investigational Site Number 360004 | Medan | |
| Ireland | Investigational Site Number 372002 | Dublin | |
| Ireland | Investigational Site Number 372003 | Dublin | |
| Ireland | Investigational Site Number 372004 | Dublin 7 | |
| Israel | Investigational Site Number 376003 | Jerusalem | |
| Israel | Investigational Site Number 376004 | Kfar Saba | |
| Israel | Investigational Site Number 376001 | Nahariya | |
| Israel | Investigational Site Number 376006 | Petah-Tikva | |
| Israel | Investigational Site Number 376007 | Tzrifin | |
| Italy | Investigational Site Number 380005 | Castellanza | |
| Italy | Investigational Site Number 380014 | Cattolica | |
| Italy | Investigational Site Number 380007 | Cesena | |
| Italy | Investigational Site Number 380015 | Cremona | |
| Italy | Investigational Site Number 380009 | Faenza | |
| Italy | Investigational Site Number 380012 | Lecce | |
| Italy | Investigational Site Number 380006 | Lugo | |
| Italy | Investigational Site Number 380001 | Meldola | |
| Italy | Investigational Site Number 380011 | Parma | |
| Italy | Investigational Site Number 380020 | Perugia | |
| Italy | Investigational Site Number 380013 | Ravenna | |
| Italy | Investigational Site Number 380016 | Rimini | |
| Italy | Investigational Site Number 380004 | Sondrio | |
| Italy | Investigational Site Number 380010 | Sora | |
| Italy | Investigational Site Number 380008 | Taormina | |
| Italy | Investigational Site Number 380019 | Terni | |
| Italy | Investigational Site Number 380003 | Treviglio | |
| Italy | Investigational Site Number 380017 | Udine | |
| Korea, Republic of | Investigational Site Number 410008 | Daegu | |
| Korea, Republic of | Investigational Site Number 410001 | Seoul | |
| Korea, Republic of | Investigational Site Number 410002 | Seoul | |
| Korea, Republic of | Investigational Site Number 410003 | Seoul | |
| Korea, Republic of | Investigational Site Number 410005 | Seoul | |
| Korea, Republic of | Investigational Site Number 410006 | Seoul | |
| Korea, Republic of | Investigational Site Number 410007 | Seoul | |
| Korea, Republic of | Investigational Site Number 410009 | Seoul | |
| Korea, Republic of | Investigational Site Number 410004 | Suwon | |
| Latvia | Investigational Site Number 428002 | Liepaja | |
| Latvia | Investigational Site Number 428001 | Riga | |
| Latvia | Investigational Site Number 428003 | Riga | |
| Lithuania | Investigational Site Number 440001 | Kaunas | |
| Lithuania | Investigational Site Number 440002 | Vilnius | |
| Malaysia | Investigational Site Number 458001 | Kota Kinabalu | |
| Malaysia | Investigational Site Number 458003 | Kuala Lumpur | |
| Malaysia | Investigational Site Number 458004 | Penang | |
| Malaysia | Investigational Site Number 458005 | Penang | |
| Mexico | Investigational Site Number 484002 | Acapulco | |
| Mexico | Investigational Site Number 484006 | Aguascalientes | |
| Mexico | Investigational Site Number 484007 | Durango | |
| Mexico | Investigational Site Number 484008 | Mérida | |
| Mexico | Investigational Site Number 484012 | Puebla | |
| Mexico | Investigational Site Number 484003 | Toluca | |
| Mexico | Investigational Site Number 484010 | Xalapa | |
| Netherlands | Investigational Site Number 528006 | Den Haag | |
| Netherlands | Investigational Site Number 528004 | Groningen | |
| Netherlands | Investigational Site Number 528005 | Helmond | |
| Netherlands | Investigational Site Number 528001 | Hoofddorp | |
| Netherlands | Investigational Site Number 528003 | Rotterdam | |
| Norway | Investigational Site Number 578001 | Oslo | |
| Peru | Investigational Site Number 604012 | Arequipa | |
| Peru | Investigational Site Number 604004 | Callao | |
| Peru | Investigational Site Number 604011 | Callao | |
| Peru | Investigational Site Number 604001 | Cercado | |
| Peru | Investigational Site Number 604002 | Chiclayo | |
| Peru | Investigational Site Number 604003 | Lima | |
| Peru | Investigational Site Number 604005 | Lima | |
| Peru | Investigational Site Number 604006 | Lima | |
| Peru | Investigational Site Number 604007 | Lima | |
| Peru | Investigational Site Number 604008 | Lima | |
| Peru | Investigational Site Number 604009 | Lima | |
| Peru | Investigational Site Number 604010 | Lima | |
| Poland | Investigational Site Number 616009 | Bialystok | |
| Poland | Investigational Site Number 616008 | Bielsko-Biala | |
| Poland | Investigational Site Number 616006 | Gliwice | |
| Poland | Investigational Site Number 616004 | Krakow | |
| Poland | Investigational Site Number 616003 | Lubin | |
| Poland | Investigational Site Number 616019 | Olsztyn | |
| Poland | Investigational Site Number 616021 | Otwock | |
| Poland | Investigational Site Number 616010 | Poznan | |
| Poland | Investigational Site Number 616001 | Prabuty | |
| Poland | Investigational Site Number 616014 | Rybnik | |
| Poland | Investigational Site Number 616005 | Rzeszow | |
| Poland | Investigational Site Number 616013 | Torun | |
| Poland | Investigational Site Number 616002 | Warszawa | |
| Poland | Investigational Site Number 616018 | Warszawa | |
| Poland | Investigational Site Number 616015 | Wroclaw | |
| Portugal | Investigational Site Number 620003 | Aveiro | |
| Portugal | Investigational Site Number 620009 | Guimarães | |
| Portugal | Investigational Site Number 620004 | Lisboa | |
| Portugal | Investigational Site Number 620008 | Matosinhos | |
| Portugal | Investigational Site Number 620007 | Porto | |
| Portugal | Investigational Site Number 620002 | Setúbal | |
| Romania | Investigational Site Number 642004 | Brasov | |
| Romania | Investigational Site Number 642002 | Bucuresti | |
| Romania | Investigational Site Number 642001 | Cluj Napoca | |
| Romania | Investigational Site Number 642006 | Cluj-Napoca | |
| Romania | Investigational Site Number 642010 | Iasi | |
| Romania | Investigational Site Number 642003 | Suceava | |
| Romania | Investigational Site Number 642008 | Timisoara | |
| Russian Federation | Investigational Site Number 643024 | Berdsk | |
| Russian Federation | Investigational Site Number 643006 | Chelyabinsk | |
| Russian Federation | Investigational Site Number 643001 | Kazan | |
| Russian Federation | Investigational Site Number 643004 | Krasnoyarsk | |
| Russian Federation | Investigational Site Number 643010 | Obninsk | |
| Russian Federation | Investigational Site Number 643005 | Omsk | |
| Russian Federation | Investigational Site Number 643022 | Pyatigorsk | |
| Russian Federation | Investigational Site Number 643023 | Rostov-On-Don | |
| Russian Federation | Investigational Site Number 643020 | Saratov | |
| Russian Federation | Investigational Site Number 643019 | Smolensk | |
| Russian Federation | Investigational Site Number 643021 | Sochi | |
| Russian Federation | Investigational Site Number 643011 | St-Petersburg | |
| Russian Federation | Investigational Site Number 643014 | St-Petersburg | |
| Russian Federation | Investigational Site Number 643015 | St-Petersburg | |
| Russian Federation | Investigational Site Number 643009 | St.Petersburg | |
| Russian Federation | Investigational Site Number 643008 | Tomsk | |
| Russian Federation | Investigational Site Number 643016 | Tula | |
| Russian Federation | Investigational Site Number 643018 | Tyumen | |
| Russian Federation | Investigational Site Number 643012 | Ufa | |
| Russian Federation | Investigational Site Number 643007 | Vladivostok | |
| Russian Federation | Investigational Site Number 643017 | Voronezh | |
| Russian Federation | Investigational Site Number 643003 | Yaroslavl | |
| Serbia | Investigational Site Number 688002 | Belgrade | |
| Serbia | Investigational Site Number 688004 | Belgrade | |
| Serbia | Investigational Site Number 688007 | Kragujevac | |
| Serbia | Investigational Site Number 688005 | Nis | |
| Slovakia | Investigational Site Number 703003 | Trnava | |
| Slovenia | Investigational Site Number 705003 | Golnik | |
| Slovenia | Investigational Site Number 705002 | Maribor | |
| South Africa | Investigational Site Number 710002 | Durban | |
| South Africa | Investigational Site Number 710003 | Durban | |
| Spain | Investigational Site Number 724008 | Barakaldo | |
| Spain | Investigational Site Number 724010 | Barakaldo | |
| Spain | Investigational Site Number 724004 | Barcelona | |
| Spain | Investigational Site Number 724006 | Islas Baleares | |
| Spain | Investigational Site Number 724011 | Lérida | |
| Spain | Investigational Site Number 724001 | Madrid | |
| Spain | Investigational Site Number 724007 | Madrid | |
| Spain | Investigational Site Number 724012 | Madrid | |
| Spain | Investigational Site Number 724013 | Madrid | |
| Spain | Investigational Site Number 724005 | Orense | |
| Spain | Investigational Site Number 724003 | Puerto De Sagunto | |
| Spain | Investigational Site Number 724002 | Valencia | |
| Sweden | Investigational Site Number 752003 | Göteborg | |
| Sweden | Investigational Site Number 752005 | Mora | |
| Sweden | Investigational Site Number 752002 | Uppsala | |
| Sweden | Investigational Site Number 752001 | Växjö | |
| Switzerland | Investigational Site Number 756006 | Aarau | |
| Switzerland | Investigational Site Number 756004 | Winterthur | |
| Taiwan | Investigational Site Number 158004 | Changhua | |
| Ukraine | Investigational Site Number 804008 | Cherkasy | |
| Ukraine | Investigational Site Number 804009 | Chernivtsi | |
| Ukraine | Investigational Site Number 804002 | Dnipropetrovsk | |
| Ukraine | Investigational Site Number 804006 | Donetsk | |
| Ukraine | Investigational Site Number 804005 | Krivoy Rog | |
| Ukraine | Investigational Site Number 804001 | Lutsk | |
| Ukraine | Investigational Site Number 804010 | Lviv | |
| Ukraine | Investigational Site Number 804011 | Sumy | |
| Ukraine | Investigational Site Number 804004 | Ternopil | |
| United Kingdom | Investigational Site Number 826016 | Bangor | |
| United Kingdom | Investigational Site Number 826010 | Brighton | |
| United Kingdom | Investigational Site Number 826015 | Coventry | |
| United Kingdom | Investigational Site Number 826013 | Dundee | |
| United Kingdom | Investigational Site Number 826007 | Hull | |
| United Kingdom | Investigational Site Number 826002 | Lincoln | |
| United Kingdom | Investigational Site Number 826017 | Lincoln | |
| United Kingdom | Investigational Site Number 826005 | Manchester | |
| United Kingdom | Investigational Site Number 826004 | Norwich | |
| United Kingdom | Investigational Site Number 826009 | Peterborough | |
| United Kingdom | Investigational Site Number 826011 | Portsmouth | |
| United Kingdom | Investigational Site Number 826001 | Shrewsbury | |
| United Kingdom | Investigational Site Number 826014 | Wirral | |
| United States | Investigational Site Number 840067 | Beaumont | Texas |
| United States | Investigational Site Number 840042 | Bethesda | Maryland |
| United States | Investigational Site Number 840006 | Birmingham | Alabama |
| United States | Investigational Site Number 840046 | Bismarck | North Dakota |
| United States | Investigational Site Number 840007 | Casa Grande | Arizona |
| United States | Investigational Site Number 840074 | Clearwater | Florida |
| United States | Investigational Site Number 840020 | Durham | North Carolina |
| United States | Investigational Site Number 840021 | Durham | North Carolina |
| United States | Investigational Site Number 840075 | East Providence | Rhode Island |
| United States | Investigational Site Number 840066 | Easton | Maryland |
| United States | Investigational Site Number 840004 | El Paso | Texas |
| United States | Investigational Site Number 840050 | Fountain Valley | California |
| United States | Investigational Site Number 840072 | Fullerton | California |
| United States | Investigational Site Number 840033 | Goshen | Indiana |
| United States | Investigational Site Number 840026 | High Point | North Carolina |
| United States | Investigational Site Number 840034 | Houston | Texas |
| United States | Investigational Site Number 840037 | Indian Wells | California |
| United States | Investigational Site Number 840010 | Indianapolis | Indiana |
| United States | Investigational Site Number 840019 | Jacksonville | Florida |
| United States | Investigational Site Number 840063 | Kennewick | Washington |
| United States | Investigational Site Number 840069 | La Verne | California |
| United States | Investigational Site Number 840009 | Long Beach | California |
| United States | Investigational Site Number 840014 | Louisville | Kentucky |
| United States | Investigational Site Number 840047 | Metairie | Louisiana |
| United States | Investigational Site Number 840003 | Middletown | Ohio |
| United States | Investigational Site Number 840048 | Mount Sterling | Kentucky |
| United States | Investigational Site Number 840005 | Norwich | Connecticut |
| United States | Investigational Site Number 840001 | Oceanside | California |
| United States | Investigational Site Number 840016 | Park Ridge | Illinois |
| United States | Investigational Site Number 840028 | Quincy | Illinois |
| United States | Investigational Site Number 840011 | Rancho Mirage | California |
| United States | Investigational Site Number 840024 | Rochester | New York |
| United States | Investigational Site Number 840051 | Rockledge | Florida |
| United States | Investigational Site Number 840070 | Roswell | Georgia |
| United States | Investigational Site Number 840032 | Ruston | Louisiana |
| United States | Investigational Site Number 840073 | Sarasota | Florida |
| United States | Investigational Site Number 840008 | Skokie | Illinois |
| United States | Investigational Site Number 840035 | Sugar Land | Texas |
| United States | Investigational Site Number 840022 | Sylvania | Ohio |
| United States | Investigational Site Number 840031 | Syracuse | New York |
| United States | Investigational Site Number 840018 | Tacoma | Washington |
| United States | Investigational Site Number 840064 | Torrington | Connecticut |
| United States | Investigational Site Number 840060 | Tucson | Arizona |
| United States | Investigational Site Number 840059 | Tupelo | Mississippi |
| United States | Investigational Site Number 840025 | Washington | District of Columbia |
| United States | Investigational Site Number 840052 | Washington | District of Columbia |
| United States | Investigational Site Number 840029 | West Covina | California |
| United States | Investigational Site Number 840038 | Woodbridge | Connecticut |
| Lead Sponsor | Collaborator |
|---|---|
| Sanofi |
United States, Argentina, Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Indonesia, Ireland, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands, Norway, Peru, Poland, Portugal, Romania, Russian Federation, Serbia, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Ukraine, United Kingdom,
Agnelli G, George DJ, Kakkar AK, Fisher W, Lassen MR, Mismetti P, Mouret P, Chaudhari U, Lawson F, Turpie AG; SAVE-ONCO Investigators. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. N Engl J Med. 2012 Feb 16;366(7):601-9 — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Platelets Count: Percentage of Participants With Potentially Clinically Significant Abnormalities [PCSA] | PCSA are abnormal values considered medically important by the Sponsor according to predefined criteria based on literature review. Thresholds for platelet counts were defined as follows: Platelets count <50 Giga/L; Platelets count =50 and <100 Giga/L; |
From first study drug injection up to 3 days after last study drug injection | Yes |
| Other | Liver Function: Percentage of Participants With Potentially Clinically Significant Abnormalities [PCSA] | Thresholds were defined as follows: Alanine Aminotransferase [ALAT] >3 Upper Normal Limit [ULN]; Total Bilirubin [TB] >2 ULN; ALAT >3 ULN and TB >2 ULN; Cases with ALAT >3 ULN and TB >2 ULN (not necessarily concomitant) were evaluated by blinded independent adjudicator to determine if they met Hy's law criteria. |
From first study drug injection up to 3 days after last study drug injection | Yes |
| Primary | Percentage of Participants Who Experienced Venous Thromboembolism Event [VTE] or VTE-related Death | VTE included any symptomatic Deep Vein Thrombosis [DVT] of lower or upper limbs and any non-fatal Pulmonary Embolism [PE] as confirmed by a Central Independent Adjudication Committee [CIAC] after review of compression ultrasound or venography for DVT, ventilation/perfusion lung scan, pulmonary angiogram or spiral computer tomography lung scan for PE. VTE-related death included fatal PE and unexplained deaths without confirmatory autopsy. Any sudden death could be classified as fatal PE by the CIAC unless diagnostic test results strongly indicated an alternative diagnosis". |
From randomization up to 3 days after last study drug injection | No |
| Primary | Time-to-first Occurrence of VTE or VTE-related Death (Cumulative Incidence Function) | Participants alive and not having experienced VTE were right censored at last study drug injection plus 3 days. In order to correct for competing risks (Deaths other than VTE-related death), a model of cause-specific hazards was used to estimate the Cumulative incidence Function with Prentice non-parametric estimator. | From randomization up to 3 days after last study drug injection | No |
| Secondary | Percentage of Participants who required the initiation of curative anticoagulant or thrombolytic treatment after VTE assessment | Initiation of curative anticoagulant or thrombolytic treatment after VTE assessment was defined from investigator's answer to the question "was the subject treated for VTE?" asked after diagnostic tests for suspected VTE and after lung imaging test for tumor evaluation. | From randomization up to 3 days after last study drug injection | No |
| Secondary | Percentage of Participants Who Experienced Clinically Relevant Bleedings | Clinically Relevant Bleedings included overt bleedings classified by the CIAC as: "major" (fatal, in a critical area/organ, causing a drop in hemoglobin =2 g/dL or requiring transfusion =2 units of blood) "clinically relevant non-major" (requiring medical intervention and not meeting criteria for major bleeding). |
From first study drug injection up to 3 days after last study drug injection | Yes |
| Secondary | Overall survival [OS] | Survival status was collected for all participants either one year after randomization, or at the study end date, (ie, 7 months following randomization of the last patient), whichever came first. OS was defined as the time from date of randomization to date of death due to any cause. Participants alive were censored at last date of contact that they were known to be alive. |
From randomization up to 1 year after randomization or 7 months following randomization of the last participant, whichever came first | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|